Limited Use Note(s) |
|
SILODOSIN4mg Cap
| Reason For Use Code | Clinical Criteria |
|---|---|
| 351 | For the management of benign prostatic hyperplasia where six weeks of treatment with other formulary alpha blockers (e.g. doxazosin, terazosin, tamsulosin) have been ineffective. |
| LU Authorization Period: Indefinite | |
| 352 | For the management of benign prostatic hyperplasia where other formulary alpha blockers (e.g. doxazosin, terazosin, tamsulosin) have produced intolerable side effects. |
| LU Authorization Period: Indefinite |